EGFR Inhibitors for Neoadjuvant and Adjuvant Therapy of NSCLC

• मुख्य लेखक: Fabio Villa (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Journal of Surgery and Surgical Research - Peertechz Publications, 2015-12-17.
• विषय: Perspective Study
• ऑनलाइन पहुंच: Connect to this object online.

<p>5-year survival rates of Non-Small Cell Lung Cancer (NSCLC) remain unsatisfactory after surgery with curative intent and disease recurrences, including distant metastases, are frequent. Only a minority of this heterogeneous disease is positive for EGFR mutations and suitable for Tyrosine Ki...